NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,644 | -75.8% | 76,635 | -76.6% | 0.00% | – |
| Q2 2023 | $188,756 | -68.9% | 328,157 | -62.0% | 0.00% | – |
| Q1 2023 | $606,512 | -37.2% | 862,872 | +101.8% | 0.00% | – |
| Q4 2022 | $966,370 | -34.5% | 427,598 | -7.3% | 0.00% | – |
| Q3 2022 | $1,476,000 | +103.0% | 461,438 | +141.2% | 0.00% | – |
| Q2 2022 | $727,000 | -46.0% | 191,338 | -23.4% | 0.00% | – |
| Q1 2022 | $1,346,000 | -98.5% | 249,872 | -96.3% | 0.00% | -100.0% |
| Q4 2021 | $91,317,000 | -63.7% | 6,759,204 | -51.7% | 0.01% | -65.0% |
| Q3 2021 | $251,579,000 | -7.5% | 14,007,745 | -11.6% | 0.02% | -4.8% |
| Q2 2021 | $271,957,000 | -23.8% | 15,848,302 | -11.1% | 0.02% | -30.0% |
| Q1 2021 | $356,688,000 | +10.7% | 17,834,382 | -5.9% | 0.03% | +3.4% |
| Q4 2020 | $322,145,000 | -0.7% | 18,949,685 | -3.1% | 0.03% | -12.1% |
| Q3 2020 | $324,481,000 | -27.0% | 19,558,797 | +2.0% | 0.03% | -32.7% |
| Q2 2020 | $444,237,000 | +27.5% | 19,181,217 | -1.7% | 0.05% | +2.1% |
| Q1 2020 | $348,341,000 | +8.0% | 19,514,890 | +30.6% | 0.05% | +33.3% |
| Q4 2019 | $322,437,000 | +34.8% | 14,938,026 | +13.8% | 0.04% | +24.1% |
| Q3 2019 | $239,163,000 | -64.0% | 13,130,036 | -29.6% | 0.03% | -62.8% |
| Q2 2019 | $663,682,000 | -3.3% | 18,653,249 | -8.7% | 0.08% | -4.9% |
| Q1 2019 | $686,344,000 | -19.6% | 20,426,894 | -21.3% | 0.08% | -29.9% |
| Q4 2018 | $853,355,000 | -41.5% | 25,961,520 | +8.5% | 0.12% | -28.7% |
| Q3 2018 | $1,458,138,000 | +16.2% | 23,919,566 | -6.9% | 0.16% | +13.9% |
| Q2 2018 | $1,255,220,000 | -51.0% | 25,705,902 | +6.7% | 0.14% | -52.6% |
| Q1 2018 | $2,560,554,000 | +281.4% | 24,097,068 | +114.3% | 0.30% | +284.8% |
| Q4 2017 | $671,430,000 | +5224.2% | 11,242,962 | +2039.7% | 0.08% | +3850.0% |
| Q3 2017 | $12,611,000 | +30.7% | 525,453 | +6.4% | 0.00% | +100.0% |
| Q2 2017 | $9,652,000 | -78.9% | 493,703 | -74.7% | 0.00% | -83.3% |
| Q1 2017 | $45,711,000 | +172.5% | 1,947,644 | +42.4% | 0.01% | +200.0% |
| Q4 2016 | $16,777,000 | -54.2% | 1,367,303 | -35.8% | 0.00% | -60.0% |
| Q3 2016 | $36,612,000 | +86.6% | 2,131,103 | +54.6% | 0.01% | +66.7% |
| Q2 2016 | $19,622,000 | -8.1% | 1,378,903 | -11.2% | 0.00% | 0.0% |
| Q1 2016 | $21,361,000 | -25.9% | 1,553,503 | -9.1% | 0.00% | -25.0% |
| Q4 2015 | $28,810,000 | +53.7% | 1,709,803 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $18,739,000 | -12.4% | 1,709,803 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $21,390,000 | +13.7% | 1,709,803 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $18,808,000 | -29.0% | 1,709,803 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $26,502,000 | +264.2% | 1,709,803 | +183.6% | 0.00% | +200.0% |
| Q3 2014 | $7,277,000 | +483.6% | 602,903 | +405.4% | 0.00% | – |
| Q3 2013 | $1,247,000 | -52.5% | 119,300 | -47.5% | 0.00% | – |
| Q2 2013 | $2,623,000 | – | 227,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |